Literature DB >> 35379380

Effect of Antimicrobial Prophylaxis on Corynebacterium bovis Infection and the Skin Microbiome of Immunodeficient Mice.

Christopher A Manuel1, Linda K Johnson2, Uma Pugazhenthi3, Derek L Fong4, Michaelk Fink5, Lauren M Habenicht4, Jori K Leszczynski4, I R Diana6, Michael J Schurr7, Daniel N Frank6.   

Abstract

Corynebacterium bovis is an opportunistic pathogen of the skin of immunodeficient mice and is sensitive to oral antibiotics that reach therapeutic blood concentrations. However, prophylactic antibiotics are considered to be ineffective at preventing C. bovis infection. In addition, the effect of C. bovis on the skin microbiome (SM) of common immunodeficient mouse strains has yet to be characterized. Consequently, we evaluated whether oral prophylactic antibiotics prevent C. bovis infection after inoculation. An infectious dose of C. bovis was applied to the skin of Hsd:Athymic Nude (nude) and NOD. Cg-Prkdcscid Il2rgtm1Wjl/SzJ (NSG) mice. Mice were then housed individually and assigned randomly to receive either untreated drinking water (Cb+Abx-group) or prophylactic amoxicillin-clavulanic acid in the drinking water (0.375 mg/mL) for 14 d (Cb+Abx+group). A third treatment group of each mouse strain was uninoculated and untreated (Cb-Abx-group). Mice from all groups were serially sampled by using dermal swabs to monitor C. bovis infection via quantitative real-time PCR and the SM via 16S rRNA sequence analysis. Fourteen days of prophylactic antibiotics prevented the perpetuation of C. bovis skin infection in both strains. Only the combination of C. bovis inoculation and oral antibiotics (Cb+Abx+) significantly affected the SM of NSG mice at day 14; this effect resolved by the end of the study (day 70). In mice that did not receive antibiotics, C. bovis significantly altered the SM of nude mice but not NSG mice at days 14 and 70. These findings demonstrate the potential benefit of prophylactic antibiotics for prevention of C. bovis infection. However, indirect effect of antibiotics on commensal bacteria and potential effects on xenograft models must be considered.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35379380      PMCID: PMC9084569          DOI: 10.30802/AALAS-CM-21-000082

Source DB:  PubMed          Journal:  Comp Med        ISSN: 1532-0820            Impact factor:   1.565


  63 in total

1.  Explicet: graphical user interface software for metadata-driven management, analysis and visualization of microbiome data.

Authors:  Charles E Robertson; J Kirk Harris; Brandie D Wagner; David Granger; Kathy Browne; Beth Tatem; Leah M Feazel; Kristin Park; Norman R Pace; Daniel N Frank
Journal:  Bioinformatics       Date:  2013-09-10       Impact factor: 6.937

2.  Base-calling of automated sequencer traces using phred. II. Error probabilities.

Authors:  B Ewing; P Green
Journal:  Genome Res       Date:  1998-03       Impact factor: 9.043

3.  Procedure for Horizontal Transfer of Patient-Derived Xenograft Tumors to Eliminate Corynebacterium bovis.

Authors:  Christopher A Manuel; Stacey M Bagby; Julie A Reisinger; Umarani Pugazhenthi; Todd M Pitts; Stephen B Keysar; John J Arcaroli; Jori K Leszczynski
Journal:  J Am Assoc Lab Anim Sci       Date:  2017-03-01       Impact factor: 1.232

4.  Antibiotic administration in the drinking water of mice.

Authors:  James O Marx; Daljit Vudathala; Lisa Murphy; Shelley Rankin; F Claire Hankenson
Journal:  J Am Assoc Lab Anim Sci       Date:  2014-05       Impact factor: 1.232

5.  Antimicrobial Susceptibility of Corynebacterium bovis Isolates from Immunodeficient Rodents.

Authors:  Anna C Fagre; Uma Pugazhenthi; Christopher Cheleuitte-Nieves; Marcus J Crim; Kenneth S Henderson; Derek L Fong; Jori K Leszczynski; Michael J Schurr; Joshua B Daniels; Christopher A Manuel
Journal:  Comp Med       Date:  2021-04-08       Impact factor: 0.982

6.  The Role of Gut Microbiota in Modulatin Tumor Growth and Anticancer Agent Efficacy.

Authors:  Jaeho Kim; Heung Kyu Lee
Journal:  Mol Cells       Date:  2021-04-23       Impact factor: 5.034

7.  Antibiotic Treatment Affects Intestinal Permeability and Gut Microbial Composition in Wistar Rats Dependent on Antibiotic Class.

Authors:  Monica Vera-Lise Tulstrup; Ellen Gerd Christensen; Vera Carvalho; Caroline Linninge; Siv Ahrné; Ole Højberg; Tine Rask Licht; Martin Iain Bahl
Journal:  PLoS One       Date:  2015-12-21       Impact factor: 3.240

8.  Intestinal microbiota enhances pancreatic carcinogenesis in preclinical models.

Authors:  Ryan M Thomas; Raad Z Gharaibeh; Josee Gauthier; Mark Beveridge; Jillian L Pope; Maria V Guijarro; Qin Yu; Zhen He; Christina Ohland; Rachel Newsome; Jose Trevino; Steven J Hughes; Mary Reinhard; Kathryn Winglee; Anthony A Fodor; Maria Zajac-Kaye; Christian Jobin
Journal:  Carcinogenesis       Date:  2018-07-30       Impact factor: 4.944

9.  Comparison of different modes of antibiotic delivery on gut microbiota depletion efficiency and body composition in mouse.

Authors:  Pauline Tirelle; Jonathan Breton; Gaëtan Riou; Pierre Déchelotte; Moïse Coëffier; David Ribet
Journal:  BMC Microbiol       Date:  2020-11-11       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.